Key facts
- This page summarizes Chris Freeman's Form 4 filing for Guardant Health, Inc. (GH).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2026, 18:11.
Chris Freeman - 01 Jul 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- GH
- Reported as of
- 01 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2026, 18:11:25 UTC
- Prior SEC filing
- 16 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John G. Saia, as attorney-in-fact for Chris Freeman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Chris Freeman filed Form 4 for Guardant Health, Inc. (GH) on 02 Jul 2026.
Change
- Previous filing in this sequence was filed on 16 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001871615
Primary reporting owner
Freeman Chris
- Relationship
- Chief Commercial Officer
- Address
- 3100 HANOVER STREET, PALO ALTO
- Signature
- /s/ John G. Saia, as attorney-in-fact for Chris Freeman
- Signature date
- 02 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,928
- Change %
- +3.2%
- Price
- $0.000000*
- Shares after
- 63,029
- Date
- 01 Jul 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,667
- Change %
- +2.6%
- Price
- $0.000000*
- Shares after
- 64,696
- Date
- 01 Jul 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,526
- Change %
- +3.9%
- Price
- $0.000000*
- Shares after
- 67,222
- Date
- 01 Jul 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,293
- Change %
- +1.9%
- Price
- $0.000000*
- Shares after
- 68,515
- Date
- 01 Jul 2026
- Ownership
- Direct
GH
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -3,141
- Change %
- -4.6%
- Price
- $170.77*
- Shares after
- 65,374
- Date
- 01 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,928
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 1,929
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,928
- Exercise price
- $0.000000
- Footnotes
- F2, F3
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,667
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 1,668
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,667
- Exercise price
- $0.000000
- Footnotes
- F3, F4
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -2,526
- Change %
- -17%
- Price
- $0.000000*
- Shares after
- 12,632
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,526
- Exercise price
- $0.000000
- Footnotes
- F3, F5
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,293
- Change %
- -13%
- Price
- $0.000000*
- Shares after
- 9,046
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,293
- Exercise price
- $0.000000
- Footnotes
- F3, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
Footnote F2
This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
Footnote F3
Not applicable for Restricted Stock Units.
Footnote F4
This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Footnote F5
This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Footnote F6
This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.